INO 10-Q: SEC filing
INOVIO Pharmaceuticals
Filed with the SEC on · accession 0001055726-26-000029
INO filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.0% by the first close after the filing.
Summary of the filing
INOVIO Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing subsequent equity financings, including a November 2026 common stock offering and prior warrant/stock issuances.
Key details
How INO stock reacted
Close before
$1.51
Nov 9, 2026
First close after
-3.97%
$1.45
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INO?
Click hereFrequently asked questions
What did INO file with the SEC on Nov 10, 2026?
INO filed a 10-Q (SEC filing). INOVIO Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing subsequent equity financings, including a November 2026 common stock offering and prior warrant/stock issuances.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did INO stock react to this filing?
INO closed at $1.51 before the filing and $1.45 on Nov 10, 2026 (-3.97%).
Other INO SEC filings
- 8-K · SEC filingNov 10, 2026
- 8-K · Secondary offeringNov 9, 2026
- 424B5 · Secondary offeringNov 6, 2026
- 8-K · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 8-K · Fda approvalNov 2, 2026
- 8-K · SEC filingOct 6, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingAug 12, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days